Bill Snyder

December 18, 2007

Vanderbilt awarded $4.4 million by the Michael J. Fox Foundation; Goal is to develop new class of Parkinson’s disease drugs

A drug discovery team at Vanderbilt University Medical Center led by Jeffrey Conn has been awarded a $4.4 million “LEAPS” grant by the Michael J. Fox Foundation for Parkinson’s Research to jump-start development of a new class of Parkinson’s diseasedrugs.

By Bill Snyder
May 4, 2006

Aeras and Vanderbilt University Announce License Deal for New TB Vaccine

The Aeras Global TB Vaccine Foundation of Bethesda, Md., and Vanderbilt University of Nashville, Tenn., announced that the two organizations had executed an exclusive license for a tuberculosis vaccine.

By Bill Snyder
May 4, 2006

Vanderbilt develops new tuberculosis vaccine

A Vanderbilt-led team of researchers has developed a new vaccine technology that may prevent the spread of tuberculosis, which kills more than two million people worldwide each year.

By Bill Snyder
October 7, 2003

Vanderbilt to participate in worldwide test of HIV vaccine

Vanderbilt University Medical Center is participating in worldwide tests of a potential vaccine that can stimulate important immune responses against the virus that causes AIDS.

By Bill Snyder
May 27, 2003

Vanderbilt, Meharry establish new Center for AIDS Research

Vanderbilt and Meharry have been collaborating with NIH for several years on research involving HIV/AIDS, which is spread primarily by sexual contact and intravenous drug use. The goal of the new grant is to encourage further collaboration between the schools, and train new investigators to advance AIDS treatment and prevention.

By Bill Snyder
1 … 112 113 114